Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Phio Pharmaceuticals Corp. (RXII)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.10.00.00.0
            Revenue growth    -100.0%-84.8%820.0%-21.1%-44.1%-52.1%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.10.00.00.0
            Gross margin     100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]4.54.65.14.73.24.03.63.3
Research and development  7.08.93.74.34.35.45.46.9
Other operating expenses       4.7  
EBITDA   [+]-11.4-13.4-8.7-8.9-7.3-14.0-9.0-10.2
            EBITDA margin     -42476.2%-5277.5%-93280.0%-47168.4%-29882.4%
Depreciation and amortization  0.10.10.10.10.10.10.10.1
EBIT   [+]-11.5-13.5-8.8-9.0-7.4-14.1-9.0-10.2
            EBIT margin     -42795.2%-5336.2%-93746.7%-47447.4%-30108.8%
Interest income, net   [+]  0.0   0.00.0
Other income (expense), net   [+]0.00.2 0.10.00.00.00.0
Pre-tax income  -11.5-13.3-8.8-8.9-7.4-14.1-9.0-10.2
Income taxes  0.00.00.00.00.0-1.60.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%11.5%0.0%0.0%
Net income  -11.5-13.3-8.8-8.9-7.4-12.5-11.1-10.4
            Net margin     -42419.0%-5333.3%-83013.3%-58257.9%-30682.4%
   
Basic EPS   [+]($10.10)($12.43)($1.92)($19.33)($57.46)($5.52)($16.41)($2.10)
Diluted EPS   [+]($10.10)($12.43)($1.92)($19.33)($57.46)($5.52)($16.41)($2.10)
   
   
Shares outstanding (basic)   [+]1.11.14.60.50.12.30.75.0
Shares outstanding (diluted)   [+]1.11.14.60.50.12.30.75.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy